Sodium‐glucose co‐transporter‐2 inhibitors and susceptibility to COVID‐19: A population‐based retrospective cohort study

Sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors are widely prescribed in people with type 2 diabetes. We aimed to investigate whether SGLT2 inhibitor prescription is associated with COVID‐19, when compared with an active comparator. We performed a propensity‐score‐matched cohort study with active...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Sainsbury, Christopher, Wang, Jingya, Gokhale, Krishna, Acosta‐Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Cooper, Jennifer, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N., Taverner, Thomas, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Cheng, Kar K., Marshall, Tom, Gkoutos, Georgios, Toulis, Konstantinos, Thomas, Neil, Tahrani, Abd, Adderley, Nicola J., Haroon, Shamil, Nirantharakumar, Krishnarajah
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2020
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537530/
https://ncbi.nlm.nih.gov/pubmed/32991065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14203
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky